Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Cabibbo

Showing results (1-10 of 225) with videos related to

Pageof 23
Sort By:
Digestive Diseases (Basel, Switzerland)|June 24, 2009
Hepatocellular cancer: optimal strategies for screening and surveillanceGiuseppe Cabibbo, Antonio Craxì
Journal of Hepatology|February 14, 2021
Antiviral therapy in the palliative setting of HCC (BCLC-B and -C)Maria Reig, Giuseppe Cabibbo
Journal of Hepatology|November 2, 2022
Radiological endpoints as surrogates for survival benefit in hepatocellular carcinoma trials: All that glitters is not goldGiuseppe Cabibbo, Jordi Bruix
World Journal of Hepatology|December 17, 2010
Needle track seeding following percutaneous procedures for hepatocellular carcinomaGiuseppe Cabibbo, Antonio Craxì
Liver International : Official Journal of the International Association for the Study of the Liver|March 28, 2009
Prognostic scores for hepatocellular carcinoma: none is the winnerCalogero Cammà, Giuseppe Cabibbo
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 3, 2023
Atezolizumab plus Bevacizumab after first-line multikinase inhibitors for advanced hepatocellular carcinoma: The concept of "drug class change"Carlo Saitta, Giuseppe Cabibbo
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2023
The prognostic role of tumour progression and liver function at progression under immunotherapy for hepatocellular carcinomaGiuseppe Cabibbo, Julien Edeline
Journal of Hepatology|November 29, 2021
The quest for precision oncology with immune checkpoint inhibitors for hepatocellular carcinomaGiuseppe Cabibbo, Amit G Singal
Hepatology (Baltimore, Md.)|December 10, 2024
The "shell game" after objective response in patients with advanced HCC treated with immunotherapyMarco Sanduzzi-Zamparelli, Giuseppe Cabibbo
Liver International : Official Journal of the International Association for the Study of the Liver|March 14, 2025
Surveillance in HCC: Making the Most of What We Have TodayMarco Sanduzzi-Zamparelli, Giuseppe Cabibbo
Pageof 23

Showing results (1-10 of 225) with videos related to

Sort By:
Pageof 23
Digestive Diseases (Basel, Switzerland)|June 24, 2009
Hepatocellular cancer: optimal strategies for screening and surveillanceGiuseppe Cabibbo, Antonio Craxì
Journal of Hepatology|February 14, 2021
Antiviral therapy in the palliative setting of HCC (BCLC-B and -C)Maria Reig, Giuseppe Cabibbo
Journal of Hepatology|November 2, 2022
Radiological endpoints as surrogates for survival benefit in hepatocellular carcinoma trials: All that glitters is not goldGiuseppe Cabibbo, Jordi Bruix
World Journal of Hepatology|December 17, 2010
Needle track seeding following percutaneous procedures for hepatocellular carcinomaGiuseppe Cabibbo, Antonio Craxì
Liver International : Official Journal of the International Association for the Study of the Liver|March 28, 2009
Prognostic scores for hepatocellular carcinoma: none is the winnerCalogero Cammà, Giuseppe Cabibbo
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 3, 2023
Atezolizumab plus Bevacizumab after first-line multikinase inhibitors for advanced hepatocellular carcinoma: The concept of "drug class change"Carlo Saitta, Giuseppe Cabibbo
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2023
The prognostic role of tumour progression and liver function at progression under immunotherapy for hepatocellular carcinomaGiuseppe Cabibbo, Julien Edeline
Journal of Hepatology|November 29, 2021
The quest for precision oncology with immune checkpoint inhibitors for hepatocellular carcinomaGiuseppe Cabibbo, Amit G Singal
Hepatology (Baltimore, Md.)|December 10, 2024
The "shell game" after objective response in patients with advanced HCC treated with immunotherapyMarco Sanduzzi-Zamparelli, Giuseppe Cabibbo
Liver International : Official Journal of the International Association for the Study of the Liver|March 14, 2025
Surveillance in HCC: Making the Most of What We Have TodayMarco Sanduzzi-Zamparelli, Giuseppe Cabibbo
Pageof 23